Katrin Mestermann
Impact in
- Oncology top 5%
- CAR-T cell therapy research
-
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 11
- CAR-T cell therapy research 11
-
- Viral Infectious Diseases and Gene Expression in Insects 3
- CRISPR and Genetic Engineering 2
- Co-authors
- Michael Hudecek (11 shared papers)Silke Frenz (4 shared papers)Hermann Einsele (4 shared papers)Thomas Nerreter (3 shared papers)Justus Weber (2 shared papers)Theodoros Giavridis (1 shared paper)Julian Rydzek (3 shared papers)Andreas Mades (2 shared papers)
- Journals
- Blood (2 papers)BioDrugs (1 paper)Science Translational Medicine (1 paper)Oncogene (1 paper)Biotechnology Journal (1 paper)
- Partner nations
- GermanySpainUnited States
In The Last Decade
Katrin Mestermann
10 papers receiving 516 citations
Katrin Mestermann's Hit Papers
Peers
Comparison fields: 5 of 40
- Oncology 441
- Immunology 146
- Genetics 132
- Biomedical Engineering 171
- Hematology 28
Countries citing papers authored by Katrin Mestermann
This map shows the geographic impact of Katrin Mestermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrin Mestermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrin Mestermann more than expected).
Fields of papers citing papers by Katrin Mestermann
This network shows the impact of papers produced by Katrin Mestermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrin Mestermann. The network helps show where Katrin Mestermann may publish in the future.
Co-authors
The 25 scholars most cited alongside Katrin Mestermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells Hit paper breakdown → | 2019 | 397 |
| 2 | 2021 | 76 | |
| 3 | 2022 | 24 | |
| 4 | 2020 | 10 | |
| 5 | 2022 | 4 | |
| 6 | 2025 | 2 | |
| 7 | 2024 | 2 | |
| 8 | 2018 | 1 | |
| 9 | 2019 | 1 | |
| 10 | 2024 | 1 | |
| 11 | 2020 | 0 |
About Katrin Mestermann
Katrin Mestermann is a scholar working on Oncology, Molecular Biology, Immunology, Genetics and Electrical and Electronic Engineering, having authored 11 papers that have together received 518 indexed citations. Recurring topics across this work include CAR-T cell therapy research (11 papers), Virus-based gene therapy research (4 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Immune Cell Function and Interaction (2 papers), Biosimilars and Bioanalytical Methods (2 papers), CRISPR and Genetic Engineering (2 papers), Nanowire Synthesis and Applications (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Oncology (441 citations), Immunology (146 citations), Genetics (132 citations), Biomedical Engineering (171 citations) and Hematology (28 citations). Katrin Mestermann has collaborated with scholars based in Germany, Spain and United States. Frequent co-authors include Michael Hudecek, Silke Frenz, Hermann Einsele, Thomas Nerreter, Justus Weber, Theodoros Giavridis, Julian Rydzek, Andreas Mades, Michel Sadelain and Razieh Monjezi. Their work appears in journals such as Blood, BioDrugs, Science Translational Medicine, Oncogene and Biotechnology Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.